Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MELATOX: Topical melatonin as sun protection
2013-003023-10Phase 2Completed
- Sponsor
- Herlev Hospital
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of melatonin (2 arms), sponsored by Herlev Hospital. Primary endpoint: Subjective sleepiness. Started Oct 2013; status: completed.
02
Drugs
melatonin
Beyond the preview
Go deeper on 2013-003023-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003023-10.